CONSTELLATION BRANDS INC's ticker is STZ and the CUSIP is 21036P108. A total of 1,127 filers reported holding CONSTELLATION BRANDS INC in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
About CONSTELLATION BRANDS INC
Constellation Brands Inc. is a leading producer and marketer of beer, wine, and spirits in the United States. The company has a diverse portfolio of brands, including Corona, Modelo, and Robert Mondavi, among others. Constellation Brands has been in the news recently due to its acquisition of a minority stake in Canopy Growth, a Canadian cannabis company.
The acquisition of Canopy Growth is a strategic move for Constellation Brands, as it allows the company to enter the rapidly growing cannabis market. The investment also gives Constellation Brands a foothold in Canada, where cannabis is legal for both medical and recreational use.
Constellation Brands has a strong track record of growth and profitability. The company has consistently delivered strong financial results, driven by its focus on premium brands and innovation. In its most recent quarter, Constellation Brands reported net sales of $2.3 billion, up 6% from the same period last year.
Despite its strong financial performance, Constellation Brands faces some challenges. The company operates in a highly competitive industry, and faces increasing pressure from craft beer and wine producers. Additionally, the company's investment in Canopy Growth is a risky move, as the cannabis market is still in its early stages and faces regulatory uncertainty.
Overall, Constellation Brands is a well-managed company with a strong portfolio of brands. The company's investment in Canopy Growth is a bold move, but one that could pay off in the long run if the cannabis market continues to grow. Investors should keep an eye on Constellation Brands as it navigates these challenges and continues to grow its business.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $116,805 | -21.1% | 454 | -16.7% | 0.01% | -18.2% |
| Q1 2024 | $148,109 | +12.4% | 545 | 0.0% | 0.01% | +10.0% |
| Q4 2023 | $131,754 | -3.8% | 545 | 0.0% | 0.01% | -16.7% |
| Q3 2023 | $136,975 | -6.5% | 545 | -8.4% | 0.01% | 0.0% |
| Q2 2023 | $146,447 | +9.0% | 595 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $134,405 | -21.1% | 595 | -19.0% | 0.01% | -20.0% |
| Q4 2022 | $170,336 | +6.5% | 735 | +5.8% | 0.02% | -31.8% |
| Q3 2022 | $160,000 | -1.2% | 695 | 0.0% | 0.02% | +4.8% |
| Q2 2022 | $162,000 | +1.2% | 695 | 0.0% | 0.02% | +23.5% |
| Q1 2022 | $160,000 | +48.1% | 695 | +61.6% | 0.02% | +54.5% |
| Q4 2021 | $108,000 | +18.7% | 430 | 0.0% | 0.01% | +10.0% |
| Q3 2021 | $91,000 | -9.9% | 430 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $101,000 | +3.1% | 430 | 0.0% | 0.01% | -8.3% |
| Q1 2021 | $98,000 | +4.3% | 430 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $94,000 | +16.0% | 430 | 0.0% | 0.01% | +9.1% |
| Q3 2020 | $81,000 | +8.0% | 430 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $75,000 | +21.0% | 430 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $62,000 | -24.4% | 430 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $82,000 | -7.9% | 430 | 0.0% | 0.01% | -15.4% |
| Q3 2019 | $89,000 | +4.7% | 430 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $85,000 | +13.3% | 430 | 0.0% | 0.01% | +18.2% |
| Q1 2019 | $75,000 | +8.7% | 430 | 0.0% | 0.01% | -8.3% |
| Q4 2018 | $69,000 | -25.8% | 430 | 0.0% | 0.01% | -7.7% |
| Q3 2018 | $93,000 | -1.1% | 430 | 0.0% | 0.01% | -13.3% |
| Q2 2018 | $94,000 | -4.1% | 430 | 0.0% | 0.02% | -6.2% |
| Q1 2018 | $98,000 | +55.6% | 430 | +56.4% | 0.02% | +60.0% |
| Q4 2017 | $63,000 | +26.0% | 275 | +10.0% | 0.01% | +25.0% |
| Q3 2017 | $50,000 | +4.2% | 250 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $48,000 | +17.1% | 250 | 0.0% | 0.01% | +14.3% |
| Q1 2017 | $41,000 | +7.9% | 250 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $38,000 | -9.5% | 250 | 0.0% | 0.01% | -12.5% |
| Q3 2016 | $42,000 | +2.4% | 250 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $41,000 | +7.9% | 250 | 0.0% | 0.01% | +14.3% |
| Q1 2016 | $38,000 | – | 250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Infusive Asset Management Inc. | 35,742 | $8,236,162 | 6.91% |
| Freshford Capital Management, LLC | 99,584 | $23,078,593 | 4.96% |
| COERENTE CAPITAL MANAGEMENT | 90,874 | $21,060 | 4.64% |
| Bain Capital Public Equity Management II, LLC | 366,031 | $84,827,684 | 4.59% |
| Bain Capital Public Equity, LP | 24,490 | $5,675,558 | 4.48% |
| Monashee Investment Management LLC | 40,000 | $9,270,000 | 3.99% |
| WISCONSIN CAPITAL MANAGEMENT LLC | 21,466 | $4,974,746 | 3.78% |
| ARMSTRONG SHAW ASSOCIATES INC/CT | 14,465 | $3,352,264 | 3.33% |
| Addison Capital Co | 22,836 | $5,292 | 3.32% |
| W.G. Shaheen & Associates DBA Whitney & Co | 69,840 | $16,185,342 | 2.97% |